Retail Pharmacies Take Big Hit After Amazon's PillPack Deal
The day the retail giant announced plans to acquire the online pharmacy company PillPack, competing retail pharmacy companies took a significant blow. Eight companies, including CVS and Rite Aid, dropped $17.5 billion in market cap in just one day.
For full interview, [click here](https://cheddar.com/videos/amazon-acquisition-of-pillpack-crushes-shares-of-walgreens-cvs-rite-aid).
From Nvidia to Microsoft, Gil Luria, D.A. Davidson senior research analyst, breaks down the Magnificent Seven, plus whether the Vision Pro can move the needle for Apple.
Suzy Batiz, founder and CEO of ~Pourri, discusses creating Poo-Pourri, building out multiple businesses, and why she believes any problem can be overcome.
Fresh off his unanimous appointment as interim CEO, Dax Dasilva shares his strategy for Lightspeed and why growth and profitability are his biggest focus.
Eddie Ghabour, co-founder and owner of KEY Advisors Wealth Management, explains why he’s investing in India, what could happen if inflation rises again, and the long-term ‘debt bubble’ looming.
The company behind Squishmallows says Build-A-Bear's new Skoosherz toys are a copy of their own plushies. Build-A-Bear filed their own suit basically responding, "No they're not!"
While tech employees worry about artificial intelligence taking over their jobs, Microsoft says Iran, North Korea, and more U.S. adversaries are beginning to use AI in cyber spying.
The self-proclaimed "only Post who worked at Kellogg" was a military veteran who fought in World War II before inventing everyone’s favorite fruit-filled breakfast ravioli.
Kevin Gordon, Senior Investment Research Manager at Charles Schwab, shares his thoughts on how investors can take advantage of the current bull market while keeping in mind the impacts of Fed policy and inflation.
